Get started
NANOSONICS LIMITEDNANOSONICS LIMITEDNANOSONICS LIMITED

NANOSONICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

NAN chart


Full chart

NAN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.40 B‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
86.70
Basic EPS (TTM)
0.05 AUD
Net income (FY)
‪12.97 M‬ AUD
Revenue (FY)
‪171.56 M‬ AUD
Shares float
‪238.78 M‬
Beta (1Y)
0.05

Employees


Employees (FY)
466
Change (1Y)
−16 −3.32%
Revenue / Employee (1Y)
‪368.16 K‬ AUD
Net income / Employee (1Y)
‪27.84 K‬ AUD

About NANOSONICS LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael Kavanagh
Website
nanosonics.com.au
Headquarters
Sydney
Founded
2000
ISIN
AU000000NAN9
FIGI
BBG000R7L8X7
Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NAN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NAN is 4.70 AUD — it has increased by 1.19% in the past 24 hours. Watch NANOSONICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NANOSONICS LIMITED stocks are traded under the ticker NAN.
NAN stock has risen by 33.86% compared to the previous week, the month change is a 26.62% rise, over the last year NANOSONICS LIMITED has showed a 75.37% increase.
We've gathered analysts' opinions on NANOSONICS LIMITED future price: according to them, NAN price has a max estimate of 6.00 AUD and a min estimate of 3.50 AUD. Watch NAN chart and read a more detailed NANOSONICS LIMITED stock forecast: see what analysts think of NANOSONICS LIMITED and suggest that you do with its stocks.
NAN reached its all-time high on Jan 5, 2021 with the price of 8.25 AUD, and its all-time low was 0.14 AUD and was reached on Jun 25, 2008. View more price dynamics on NAN chart.
See other stocks reaching their highest and lowest prices.
NAN stock is 4.91% volatile and has beta coefficient of 0.05. Track NANOSONICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is NANOSONICS LIMITED there?
Today NANOSONICS LIMITED has the market capitalization of ‪1.41 B‬, it has decreased by −1.49% over the last week.
Yes, you can track NANOSONICS LIMITED financials in yearly and quarterly reports right on TradingView.
NANOSONICS LIMITED is going to release the next earnings report on Sep 1, 2025. Keep track of upcoming events with our Earnings Calendar.
NAN earnings for the last half-year are 0.03 AUD per share, whereas the estimation was 0.02 AUD, resulting in a 46.70% surprise. The estimated earnings for the next half-year are 0.03 AUD per share. See more details about NANOSONICS LIMITED earnings.
NANOSONICS LIMITED revenue for the last half-year amounts to ‪93.60 M‬ AUD, despite the estimated figure of ‪91.83 M‬ AUD. In the next half-year revenue is expected to reach ‪99.55 M‬ AUD.
NAN net income for the last half-year is ‪9.76 M‬ AUD, while the previous report showed ‪6.80 M‬ AUD of net income which accounts for 43.45% change. Track more NANOSONICS LIMITED financial stats to get the full picture.
No, NAN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 26, 2025, the company has 466.00 employees. See our rating of the largest employees — is NANOSONICS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANOSONICS LIMITED EBITDA is ‪19.14 M‬ AUD, and current EBITDA margin is 9.34%. See more stats in NANOSONICS LIMITED financial statements.
Like other stocks, NAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOSONICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANOSONICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANOSONICS LIMITED stock shows the strong buy signal. See more of NANOSONICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.